General Information of Drug (ID: DM5FHUP)

Drug Name
RP103
Synonyms
Cysteamine bitartrate; UNII-QO84GZ3TST; QO84GZ3TST; CYSTEAMINE BITARTRATE; Procysbi; Procysbi (TN); EINECS 248-641-7; Cysteamine bitartrate (JAN); beta-Mercaptoethylamine bitartrate; AKOS032954217; beta-Mercaptoethylamine hydrogen tartrate; D10468; Ethanethiol, 2-amino-, tartrate (1:1) (salt)
Indication
Disease Entry ICD 11 Status REF
Huntington disease 8A01.10 Phase 2/3 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C6H13NO6S
Canonical SMILES
C(CS)N.C(C(C(=O)O)O)(C(=O)O)O
InChI
1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1
InChIKey
NSKJTUFFDRENDM-ZVGUSBNCSA-N
Cross-matching ID
PubChem CID
11958147
CAS Number
27761-19-9
TTD ID
D0VD6Q

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)